Endocrine Reviews

Papers
(The TQCC of Endocrine Reviews is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Papillary Craniopharyngioma: An Integrative and Comprehensive Review473
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway275
Endocrine Manifestations and New Developments in Mitochondrial Disease241
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”234
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes203
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies200
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases178
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention175
The Molecular Biology of Midgut Neuroendocrine Neoplasms172
Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing’s Syndrome160
The Pregnancy-Associated Plasma Protein-A (PAPP-A) Story157
The β Cell in Diabetes: Integrating Biomarkers With Functional Measures136
Correction to: “The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty”124
Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies92
Stem Cells and Organs-on-chips: New Promising Technologies for Human Infertility Treatment88
The Biology and Clinical Implications of PCSK786
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors86
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism76
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?75
Post-translational Modifications: The Signals at the Intersection of Exercise, Glucose Uptake, and Insulin Sensitivity74
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status74
Estrogen Receptor Signaling in the Immune System74
Erratum to: “The Relationship Between Bone and Reproductive Hormones Beyond Estrogens and Androgens”72
Contemporary Biological Insights and Clinical Management of Craniopharyngioma70
New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature66
Time-restricted Eating for the Prevention and Management of Metabolic Diseases60
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas60
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance59
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction56
The Metabolic Role and Therapeutic Potential of the Microbiome54
Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review53
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling52
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia52
Adiponectin and Adiponectin Receptors in Atherosclerosis52
The Cortisol Awakening Response: Regulation and Functional Significance50
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease50
Imaging of Pheochromocytomas and Paragangliomas49
International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood48
0.034431934356689